DK3431078T3 - Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse - Google Patents

Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse Download PDF

Info

Publication number: DK3431078T3
Authority: DK; Denmark
Prior art keywords: betahistic; compositions; extended release; oral fixed; pulse extended
Prior art date: 2017-07-20

Application number

DK17189264.9T

Other languages

English (en)

Inventor

Himanshukumar Dasharathlal Patel

Vinod Purushottam Dube

Venkata Ramana Naidu

Sunil Shantwan Borude

Original Assignee

Intas Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-07-20

Filing date

2017-09-04

Publication date

2021-04-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59829185&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3431078(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-09-04 Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd

2021-04-19 Application granted granted Critical

2021-04-19 Publication of DK3431078T3 publication Critical patent/DK3431078T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Cosmetics (AREA)

DK17189264.9T 2017-07-20 2017-09-04 Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse DK3431078T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN201721025857		2017-07-20

Publications (1)

Publication Number	Publication Date
DK3431078T3 true DK3431078T3 (da)	2021-04-19

Family

ID=59829185

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK17189264.9T DK3431078T3 (da)	2017-07-20	2017-09-04	Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse

Country Status (22)

Country	Link
US (1)	US11433058B2 (da)
EP (2)	EP3431078B1 (da)
JP (1)	JP7084950B2 (da)
CN (2)	CN122537319A (da)
AR (1)	AR112281A1 (da)
AU (1)	AU2018302771B2 (da)
CA (1)	CA3069282A1 (da)
CL (1)	CL2020000124A1 (da)
CO (1)	CO2020001742A2 (da)
DK (1)	DK3431078T3 (da)
ES (1)	ES2862209T3 (da)
HR (1)	HRP20210570T1 (da)
LT (1)	LT3431078T (da)
MX (1)	MX2020000702A (da)
MY (1)	MY201082A (da)
PH (1)	PH12020500001A1 (da)
PL (1)	PL3431078T3 (da)
PT (1)	PT3431078T (da)
SA (1)	SA520411067B1 (da)
UY (1)	UY37798A (da)
WO (1)	WO2019016668A1 (da)
ZA (1)	ZA202000030B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115266955B (zh) *	2021-04-29	2024-10-01	景忠山国药（唐山）有限公司	基于一测多评法的耳聋胶囊中成分含量的检测方法
WO2026069175A1 (en) *	2024-09-25	2026-04-02	Unison Pharmaceuticals Pvt. Ltd.	A prolonged-release pharmaceutical composition comprising betahistine or salt thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1309591B1 (it) *	1999-03-05	2002-01-24	Formenti Farmaceutici Spa	Composizioni a rilascio controllato di betaistina.
KR20030034171A (ko) *	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	옥시모르폰 제어 방출 제형
TWI319713B (en) *	2002-10-25	2010-01-21		Sustained-release tramadol formulations with 24-hour efficacy
DK1493435T3 (da) *	2003-07-04	2008-09-08	Formenti Farmaceutici Spa	Sammensætning af betahistin med styret frigivelse
WO2012131722A1 (en) *	2011-03-30	2012-10-04	Sun Pharma Advanced Research Company Ltd.	Controlled release composition of betahistine
DE102012105528A1 (de)	2012-06-25	2014-01-02	Hennig Arzneimittel Gmbh & Co. Kg	Arzneiform zur Freisetzung von Wirkstoffen
WO2014174073A1 (en) *	2013-04-26	2014-10-30	Sandoz Ag	Sustained release formulations of tofacitinib

2017
- 2017-09-04 PT PT171892649T patent/PT3431078T/pt unknown
- 2017-09-04 PL PL17189264T patent/PL3431078T3/pl unknown
- 2017-09-04 DK DK17189264.9T patent/DK3431078T3/da active
- 2017-09-04 LT LTEP17189264.9T patent/LT3431078T/lt unknown
- 2017-09-04 EP EP17189264.9A patent/EP3431078B1/en active Active
- 2017-09-04 ES ES17189264T patent/ES2862209T3/es active Active
2018
- 2018-07-05 UY UY0001037798A patent/UY37798A/es not_active Application Discontinuation
- 2018-07-16 JP JP2019570397A patent/JP7084950B2/ja active Active
- 2018-07-16 WO PCT/IB2018/055233 patent/WO2019016668A1/en not_active Ceased
- 2018-07-16 MY MYPI2019007784A patent/MY201082A/en unknown
- 2018-07-16 EP EP18835809.7A patent/EP3654954A4/en not_active Withdrawn
- 2018-07-16 CA CA3069282A patent/CA3069282A1/en active Pending
- 2018-07-16 CN CN202610844919.1A patent/CN122537319A/zh active Pending
- 2018-07-16 US US16/632,500 patent/US11433058B2/en active Active
- 2018-07-16 MX MX2020000702A patent/MX2020000702A/es unknown
- 2018-07-16 AU AU2018302771A patent/AU2018302771B2/en active Active
- 2018-07-16 CN CN201880047204.7A patent/CN110891551A/zh active Pending
- 2018-07-19 AR ARP180102029 patent/AR112281A1/es unknown
2020
- 2020-01-02 ZA ZA2020/00030A patent/ZA202000030B/en unknown
- 2020-01-02 PH PH12020500001A patent/PH12020500001A1/en unknown
- 2020-01-16 SA SA520411067A patent/SA520411067B1/ar unknown
- 2020-01-16 CL CL2020000124A patent/CL2020000124A1/es unknown
- 2020-02-14 CO CONC2020/0001742A patent/CO2020001742A2/es unknown
2021
- 2021-04-09 HR HRP20210570TT patent/HRP20210570T1/hr unknown

Also Published As

Publication number	Publication date
CA3069282A1 (en)	2019-01-24
CN110891551A (zh)	2020-03-17
US11433058B2 (en)	2022-09-06
EP3654954A1 (en)	2020-05-27
PL3431078T3 (pl)	2021-07-12
LT3431078T (lt)	2021-05-10
AR112281A1 (es)	2019-10-09
CL2020000124A1 (es)	2020-09-21
HRP20210570T1 (hr)	2021-09-03
EP3431078A1 (en)	2019-01-23
CO2020001742A2 (es)	2020-02-28
BR112020000977A2 (pt)	2020-07-14
WO2019016668A1 (en)	2019-01-24
AU2018302771A1 (en)	2020-01-16
US20210161871A1 (en)	2021-06-03
PT3431078T (pt)	2021-04-21
ZA202000030B (en)	2021-08-25
NZ761043A (en)	2025-11-28
SA520411067B1 (ar)	2022-09-28
UY37798A (es)	2019-01-02
JP2020528045A (ja)	2020-09-17
PH12020500001A1 (en)	2020-09-14
RU2020101925A (ru)	2021-08-20
MY201082A (en)	2024-02-03
AU2018302771B2 (en)	2022-05-12
EP3654954A4 (en)	2021-06-16
EP3431078B1 (en)	2021-01-20
CN122537319A (zh)	2026-08-11
JP7084950B2 (ja)	2022-06-15
ES2862209T3 (es)	2021-10-07
MX2020000702A (es)	2020-10-14
RU2020101925A3 (da)	2021-08-27

Publication	Publication Date	Title
EP3423037A4 (en)	2019-11-27	ORAL ADMINISTRATIVE COMPOSITION
IL268852A (en)	2019-10-31	Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan
EP3606559C0 (en)	2024-06-05	BIOORTHOGONAL COMPOSITIONS
DK3642202T3 (da)	2023-01-30	Dihydro-pyrrolo-pyridin-derivater
DK2968155T3 (da)	2021-04-19	Orale tofacitinib-doseringsformer med langvarig frigivelse
DK3244878T3 (da)	2022-10-17	Faste orale sammensætningsformer
EP3383328C0 (en)	2025-09-10	ADJUSTABLE ORAL APPLIANCE FOR SLEEP APNEA
EP3685682C0 (en)	2023-06-07	Oral rehydration composition
SG11201509424VA (en)	2015-12-30	4'-fluor0-2'-methyl substituted nucleoside derivatives
EP3688111A4 (en)	2021-07-28	THERMAL CONDUCTIVE COMPOSITION
PL3703518T3 (pl)	2024-11-12	Formulacja ulegająca aerozolowaniu
LT3651736T (lt)	2021-10-11	Ilgai veikiančios kompozicijos
DK3041579T3 (da)	2023-06-19	Orale antiparasitære sammensætninger
EP3565532A4 (en)	2020-10-28	ORAL DISPERSIBLE FILM COMPOSITION
DK4234656T3 (da)	2026-04-20	Sammensætninger
EP3548037A4 (en)	2020-07-29	ORAL TESTOSTERONE TRIDECANOATE THERAPY
FR3027521B1 (fr)	2016-12-16	Compositions pour administration par voie orale
DK3706724T3 (da)	2024-10-14	Orale rifamycin-sv-sammensætninger
EP3582748A4 (en)	2020-12-02	SULPHATE-FREE FORMULATIONS
EP3756471A4 (en)	2021-11-10	ORAL INGESTION COMPOSITION
DK3411008T3 (da)	2023-08-14	Sammensætninger omfattende aktive solbeskyttelsesmidler med polyhydroxyfulleren
DK3071191T3 (da)	2022-03-07	Faste orale sammensætninger med langsom frigivelse
LT3680243T (lt)	2021-11-25	Pentaciklinis junginys
EP3793609C0 (en)	2023-12-13	ORAL SOLUTION FORMULATION
DK3638211T3 (da)	2024-01-22	Farmaceutiske sammensætninger med forsinket vedvarende frigivelse